MiniMed officer files initial Form 3

MiniMed Group, Inc. filed an initial insider ownership report for officer Chandrasena Gillian on Form 3.

Rhea-AI Filing Summary

MiniMed Group, Inc. filed an initial insider ownership report for officer Chandrasena Gillian on Form 3. The data provided shows no reported transactions, no buy or sell activity, and no derivative positions, indicating this filing is primarily a baseline disclosure of status as an officer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MiniMed Group (MMED) Form 3 filing for Chandrasena Gillian show?

The Form 3 for MiniMed Group (MMED) reports officer Chandrasena Gillian as an insider. The excerpted data shows no transactions, no buy or sell activity, and no derivative positions, serving mainly as an initial baseline ownership disclosure for this reporting person.

Did Chandrasena Gillian buy or sell MiniMed Group (MMED) shares in this Form 3?

No transactions are shown for Chandrasena Gillian in this Form 3 excerpt. The transaction summary lists zero buys, zero sells, zero exercises, and zero gifts, indicating no reportable trading activity is included in the provided data for this initial ownership statement.

Are there any MiniMed Group (MMED) options or derivatives reported for Chandrasena Gillian?

The filing excerpt lists an empty derivativeSummary, meaning no options, warrants, or other derivative securities are reported for Chandrasena Gillian here. The transaction summary also shows zero derivative transactions, reinforcing the absence of disclosed derivative positions in this data set.

What insider role does Chandrasena Gillian have at MiniMed Group (MMED)?

Chandrasena Gillian is identified as an officer of MiniMed Group, Inc. The officer title field states “See Remarks,” indicating the specific position is referenced elsewhere, but it is not detailed in the provided excerpt of this Form 3 ownership filing.

Why is this MiniMed Group (MMED) Form 3 important for investors?

This Form 3 establishes Chandrasena Gillian as a reporting officer of MiniMed Group, Inc. Initial ownership filings help investors track which executives are subject to insider reporting, even when no transactions or derivative holdings are disclosed in the available data excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 06:14 PM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chandrasena Gillian

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

SVP, Chief Human Resources Officer Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.